These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24986662)

  • 1. Stereochemical modification of geminal dialkyl substituents on pantothenamides alters antimicrobial activity.
    Hoegl A; Darabi H; Tran E; Awuah E; Kerdo ES; Habib E; Saliba KJ; Auclair K
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3274-7. PubMed ID: 24986662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geminal dialkyl derivatives of N-substituted pantothenamides: synthesis and antibacterial activity.
    Akinnusi TO; Vong K; Auclair K
    Bioorg Med Chem; 2011 Apr; 19(8):2696-706. PubMed ID: 21440446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria.
    Jansen PA; Hermkens PH; Zeeuwen PL; Botman PN; Blaauw RH; Burghout P; van Galen PM; Mouton JW; Rutjes FP; Schalkwijk J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4794-800. PubMed ID: 23877685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in pantothenate kinase type determines the pantothenamide mode of action and impacts on coenzyme A salvage biosynthesis.
    de Villiers M; Barnard L; Koekemoer L; Snoep JL; Strauss E
    FEBS J; 2014 Oct; 281(20):4731-53. PubMed ID: 25156889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target.
    de Villiers M; Spry C; Macuamule CJ; Barnard L; Wells G; Saliba KJ; Strauss E
    ACS Infect Dis; 2017 Jul; 3(7):527-541. PubMed ID: 28437604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated.
    Spry C; Macuamule C; Lin Z; Virga KG; Lee RE; Strauss E; Saliba KJ
    PLoS One; 2013; 8(2):e54974. PubMed ID: 23405100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action.
    Barnard L; Mostert KJ; van Otterlo WAL; Strauss E
    ACS Infect Dis; 2018 May; 4(5):736-743. PubMed ID: 29332383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel pantothenate derivatives for anti-malarial chemotherapy.
    Pett HE; Jansen PA; Hermkens PH; Botman PN; Beuckens-Schortinghuis CA; Blaauw RH; Graumans W; van de Vegte-Bolmer M; Koolen KM; Rutjes FP; Dechering KJ; Sauerwein RW; Schalkwijk J
    Malar J; 2015 Apr; 14():169. PubMed ID: 25927675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
    Awuah E; Ma E; Hoegl A; Vong K; Habib E; Auclair K
    Bioorg Med Chem; 2014 Jun; 22(12):3083-90. PubMed ID: 24814884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency.
    Howieson VM; Tran E; Hoegl A; Fam HL; Fu J; Sivonen K; Li XX; Auclair K; Saliba KJ
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7146-7152. PubMed ID: 27645235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N-substituted pantothenamides.
    Li B; Tempel W; Smil D; Bolshan Y; Schapira M; Park HW
    Proteins; 2013 Aug; 81(8):1466-72. PubMed ID: 23553820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a Stable and Potent Coenzyme A-Targeting Antiplasmodial Agent: Structure-Activity Relationship Studies of
    Spry C; Barnard L; Kok M; Powell AK; Mahesh D; Tjhin ET; Saliba KJ; Strauss E; de Villiers M
    ACS Infect Dis; 2020 Jul; 6(7):1844-1854. PubMed ID: 32375471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of Antiplasmodial Pantothenamide Analogues Reveal a New Way by Which Triazoles Mimic Amide Bonds.
    Guan J; Tjhin ET; Howieson VM; Kittikool T; Spry C; Saliba KJ; Auclair K
    ChemMedChem; 2018 Dec; 13(24):2677-2683. PubMed ID: 30370998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites.
    Zhang YM; Frank MW; Virga KG; Lee RE; Rock CO; Jackowski S
    J Biol Chem; 2004 Dec; 279(49):50969-75. PubMed ID: 15459190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibiotic activity of N-pentylpantothenamide results from its conversion to ethyldethia-coenzyme a, a coenzyme a antimetabolite.
    Strauss E; Begley TP
    J Biol Chem; 2002 Dec; 277(50):48205-9. PubMed ID: 12372838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity analysis of CJ-15,801 analogues that interact with Plasmodium falciparum pantothenate kinase and inhibit parasite proliferation.
    Spry C; Sewell AL; Hering Y; Villa MVJ; Weber J; Hobson SJ; Harnor SJ; Gul S; Marquez R; Saliba KJ
    Eur J Med Chem; 2018 Jan; 143():1139-1147. PubMed ID: 29233590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a method for the parallel synthesis and purification of N-substituted pantothenamides, known inhibitors of coenzyme A biosynthesis and utilization.
    van Wyk M; Strauss E
    Org Biomol Chem; 2008 Dec; 6(23):4348-55. PubMed ID: 19005594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of N-pentylpantothenamide is due to inhibition of coenzyme a synthesis.
    Thomas J; Cronan JE
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1374-7. PubMed ID: 20047918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibiotic CJ-15,801 is an antimetabolite that hijacks and then inhibits CoA biosynthesis.
    van der Westhuyzen R; Hammons JC; Meier JL; Dahesh S; Moolman WJ; Pelly SC; Nizet V; Burkart MD; Strauss E
    Chem Biol; 2012 May; 19(5):559-71. PubMed ID: 22633408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of (-)-deoxypseudophrynaminol versus its racemate and derivatives.
    Dix AV; Meseck CM; Lowe AJ; Mitchell MO
    Bioorg Med Chem Lett; 2006 May; 16(9):2522-4. PubMed ID: 16464587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.